Wolfe Research analyst Andy Chen reiterated a Peerperform rating on Apellis Pharmaceuticals (NASDAQ: APLS)The analyst commented, "This morning, Biogen announced ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE